We assessed lung collagen i n human i n f a n t s a t r i s k f o r chronic lung disease (CLD) because Type I collagen i s increased i n a d u l t RDS, and i d i o p a t h i c o r experimental pulmonary f i b r o s i s .
i n f a n t s who died w h i l e r e c e i v i n g mechanical v e n t i l a t i o n , and i n 3 s t i l l b o r n i n f a n t s . W e analyzed lung t i s s u e by CNBr digestion, column chromatography and index polypeptide separation by polyacrylamide gel electrophoresis. To decrease the i n f l u e n c e o f measurement e r r o r o f Type I collagen, we c a l c u l a t e d r a t i o s o f Type I t o I 1 1 collagen. W e then compared i n f a n t s w i t h c l i n i c a l and/or pathological CLD t o those without CLD using pooled variance techniaues and one t a i l e d t -t e s t s .
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We observed a s i g n i f i c a n t increase i n Type I f 1 1 1 collagen w i t h CLD. No aeneral r e l a t i o n s h i n between t o t a l v e n t i l a t o r time and collagen-11111 r a t i o s existed, b u t b a c t e r i a l pneumonia may have been c o n t r i b u t o r y t o r a p i d l y developing CLD. A l l i n f a n t s w i t h pathologic CLD had increased Type I collagen. Two i n f a n t s dying e a r l y w i t h very high 11111 r a t i o s had evidence o f prenatal b r a i n damage, suggesting t h a t some increased collagen synthesis may be t h e r e s u l t o f prenatal lung i n j u r y . Aminophylline (A) is often used to treat apnea of prematurity. TO determine response times, optimal length of therapy, effectiveness of A in relation to gestational age (GA) and postnatal age (PA), we conducted a randomized, blinded controlled study in 45 premature infants with recurrent apnea. Infants were divided into 2 groups. Group I (n=23, BW=1395?359g, GA=3122wks., PA=3.22 2d) received A (mean serum level 8. hncg/ml) and Group I1 (n=22, BW=1306?336g, GA=3022wks., PA=2.321.8d). Results: In infants not requiring assisted ventilation (AV): Group I (18/22) had less apnea 24 hours after institutior~ of therapy (pC.025) and apnea ended in 67% of the infants by the 7th day. In 3 infants, apnea was minimally reduced (<25%) during the first 7 d and persisted for 4 weeks despite continued therapy. Group I1 (14/23) did not show a significant decrease in apnea until 72 hours and only 35% were free of apnea by 7th day. Apnea persisted in 3 infants for 4 weeks. In infants requiring AV: similar numbers in both groups developed respiratory failure. Twelve of the 13 infants needing AV were 5 31 GA and had > 4 apneic episodes during the first 24 hours PA. Conclusion:
does not prevent respiratory failure and is not effective in infants 5 31 wks. GA with early onset repetitive apnea. Twenty percent of premature infants are refractory to A and can be identified by evaluating their response within the first 7 days of therapy. Prolonged treatment with A is not an effective therapy for apnea of prematurity.
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Previous studies suggest that preterm infants lack the ventilatory reserve necessary to compensate for an additional inspiratory load. Theophylline (TH) is oftell prescribed for apnea of prematurity and bronchopulmonary dysplasia. To evaluate the effect of TH on ventilatory parameters, seven preterm infants 6 2 SEM: 29.6 2 .92 weeks gestation; 1.24 2 .14 kg birthweight) were challenged with an externally applied inspiratory resistive load (300 cm H20/L/sec). The infants were studied at a mean age of 46.3 t 9.3 days, weight of 1.75 2 .19 kg, and TH level of 7.6 2 .9 mg%.
Tidal volume (VT), frequency (f) , minute ventilation (MV) inspiratoryltotal breath time (Ti/~tot) and work of breathing (WOB) were assessed during spontaneous unloaded (UL) and loaded (L)breathing. Heart rate, transcutaneous 01 and COO tensions were continuouslv monitored. Hypoxemia is common in newborns with Group B Streptococcal (GBS) sepsis, yet the mechanism of abnormal gas exchange in this disease is unknown. We studied ventilation-perfusion matching (VA/Q) and shunt fraction using the multiple inert gas elimination in 7 newborn piglets receiving live GBS. Measurements were made in anesthetized animals ventilated with room air bgfore, during, and after a 30 min intravenous infusion of 2x10 colony forming unitslkg of GBS. Shunt fraction was measured by sulfur hexafluoride retention and standard deviation of distribution of pulmonary blood flow (sdPBF) was used as an index of VA/Q heterogeneity. Changes are depicted below; *denotes p<.05.
Base Pa0 , CO and PvO fell while Ppa and sdPBF increased significan$ly during GBS infusion. Shunt increased to >6% in only 2 of the animals. We conclude that arterial hypoxemia during GBS sepsis in newborn piglets results primarily from diminished cardiac output with resultant fall in mixed venous oxygen tension along with an increase in VA/Q heterogeneity within the lungs.
NON-INVASIVE MONITORING OF BLOOD GAS PARAMETERS IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH CHRONIC PULMONARY DISEASE. Marilyn E. Alley and Alexander
Spock, Duke University Medical Center, Department of Pediatrics, Durham, N. C. Evaluation of respiratory function in patients with chronic lung disease is usually performed by clinical evaluation, chest x-ray, pulmonary function tests and blood gas analyses. Noninvasive techniques have been utilized for inpatient but not outpatient monitoring of blood gas parameters in chronic lung disease. In this study we prospectively compared the results of non-invasive techniques, as measured by an IL capnograph for PEC02 and a BIOX oximeter for oxygen saturation (SoxOL), with arterialized blood gas values (Sa02, Pa02, PaC02) in 45 consecutive patients in the age range of 6 to 31 years. From these data, the Sa02 and Pa02 are both predictable from the SoxO2, as is the PaC02 from the PECO2. This indicates that the capnograph and oximeter can be used effectively to noninvasively monitor blood gas parameters in patients with chronic pulmonary disease, particularly in pediatric patients. Any abnormalities or variation can be confirmed by blood gas levels. The purpose of this study was to evaluate the effects on-the cardiovascular system of HFJV compared to CV. Seven dogs (x=19.6 Kg) were monitored for 1 hour on CV, followed by 1 hour of HFJV, and were then returned to CV. Dogs were anaesthetized with pentobarbital and the skeletal musculature blocked with pavulon. Thermal dilution cardiac output, (C01, systemic and pulmonary arterial pressure were obtained at 20 min intervals. A Harvard volume respirator was set at VT of 200 and rate of 24. A Healthdyne model 300 high frequency ventilator was set at a mean rate of 120 and a drive pressure of 30, to achieve a similar peak pressure (i=13) and PEEP (x=2.5) as on CV. Blood gases remained within the normal ranqe with both forms of ventilation.
HEMODYNAMIC EFFECTS OF HIGH FREQUENCY JET VENTILATION

(HFJV) AND CONVENTIONAL VENTILATION (CV)
( .4 There was a significant (p <0.01), progressive fall in CO, due to a fall in stroke volume (SV). Mean arterial pressure (MAP) was maintained as both systemic vascular reslstance (SVR) and pulmonary vascular resistance (PVR) significantly increased ( p rO.O1). These results most likely reflect compensation to a temporal fall in CO and not differences between CV and HFJV.
